 |
Corporate News
26-Mar-24
|
|
|
|
|
|
|
|
|
|
|
|
Gland Pharma allots 2,400 equity shares under ESOS
|
|
|
|
|
|
|
|
Gland Pharma has allotted 2,400 equity shares under ESOS on 25 March 2024. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 164,710,523 /- comprising of 164,710,523 Equity shares of face value Re.1/- each.
|
|
|
|
Previous News |
Stock alert: Gland Pharma, Gujarat Fluorochem, Ujjivan SFB, Prestige Estates, IREDA
(
Market Commentary
-
Stock Alert
24-Jun-24
08:41
)
|
|
|
Gland Pharma's Pashamylaram unit clears USFDA inspection
(
Corporate News
-
24-Nov-23
10:34
)
|
|
|
Gland Pharma appoints Chief Operating Officer
(
Corporate News
-
29-Apr-24
14:51
)
|
|
|
Gland Pharma spurts after Hyderabad facility gets EIR from USFDA
(
Hot Pursuit
-
24-Nov-23
10:58
)
|
|
|
Volumes spurt at Gland Pharma Ltd counter
(
Hot Pursuit
-
07-Nov-23
11:00
)
|
|
|
Gland Pharma consolidated net profit declines 15.05% in the December 2022 quarter
(
Results
-
Announcements
23-Jan-23
17:31
)
|
|
|
Gland Pharma Ltd soars 1.09%, Gains for third straight session
(
Hot Pursuit
-
12-Dec-23
13:05
)
|
|
|
Gland Pharma consolidated net profit declines 17.28% in the December 2023 quarter
(
Results
-
Announcements
14-Feb-24
17:22
)
|
|
|
Gland Pharma to table results
(
Corporate News
-
09-May-24
14:47
)
|
|
|
US FDA concludes inspection of Gland Pharma's Visakhapatnam facility with zero observations
(
Hot Pursuit
-
28-Jan-23
09:23
)
|
|
|
Gland Pharma's Visakhapatnam facility concludes USFDA inspection
(
Corporate News
-
27-Jan-23
15:26
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|